| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | AU$ 383.68M | AU$ 408.10M | AU$ 388.15M | AU$ 183.59M | AU$ 157.15M |
| Gross Profit | AU$ 192.21M | AU$ 247.27M | AU$ 218.53M | AU$ 26.84M | AU$ 23.75M |
| Operating Income | AU$ -34.28M | AU$ -23.59M | AU$ -139.06M | AU$ -186.44M | AU$ -121.88M |
| EBITDA | AU$ 29.40M | AU$ 42.08M | AU$ -116.93M | AU$ -193.80M | AU$ -78.88M |
| Net Income | AU$ 24.47M | AU$ -93.84M | AU$ -174.23M | AU$ 117.25M | AU$ -281.29M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | AU$ 82.25M | AU$ 100.40M | AU$ 149.28M | AU$ 220.14M | AU$ 97.08M |
| Total Assets | AU$ 909.45M | AU$ 1.01B | AU$ 1.14B | AU$ 1.25B | AU$ 1.30B |
| Total Debt | AU$ 43.20M | AU$ 41.27M | AU$ 38.82M | AU$ 47.51M | AU$ 413.67M |
| Net Debt | AU$ -39.05M | AU$ -18.57M | AU$ -71.25M | AU$ -54.21M | AU$ 316.59M |
| Total Liabilities | AU$ 518.50M | AU$ 644.32M | AU$ 688.99M | AU$ 613.77M | AU$ 764.89M |
| Stockholders' Equity | AU$ 390.94M | AU$ 370.28M | AU$ 454.19M | AU$ 634.36M | AU$ 545.88M |
| Cash Flow | |||||
| Free Cash Flow | AU$ 12.67M | AU$ 5.19M | AU$ -36.16M | AU$ -262.71M | AU$ -28.47M |
| Operating Cash Flow | AU$ 15.62M | AU$ 17.47M | AU$ -15.30M | AU$ -43.12M | AU$ -16.62M |
| Investing Cash Flow | AU$ 10.00M | AU$ -68.07M | AU$ 53.45M | AU$ 473.49M | AU$ -28.53M |
| Financing Cash Flow | AU$ -3.23M | AU$ -556.00K | AU$ -19.85M | AU$ -431.48M | AU$ 27.60M |
Mayne Pharma Group (MAYNF)
OTHER OTC:MAYNF
